EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudie

Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a propensity score-adjusted retrospective cohort study

Davide Fiore Bavaro, Alessandra Belati, Lucia Diella, Luisa Frallonardo, Giacomo Guido, Roberta Papagni, Carmen Pellegrino, Gaetano Brindicci, Nicolò De Gennaro, Francesco Di Gennaro, Sofia Denicolò, Luigi Ronga und 7 weitere

Journal of Antimicrobial Chemotherapy · 05.09.2023 · 78 (9) · 2175-2184

DOI: 10.1093/jac/dkad215 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 10.07.2023. Verfasst von Davide Fiore Bavaro und 18 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Infectious Diseases, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, Policlinic of Bari, Piazza Giul…. Hauptthemen laut MEDLINE: Gram-Negative Bacterial Infections, Sepsis, Bacteremia. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Optimal β-lactam dosing for the treatment of Gram-negative bacteria bloodstream infections (GNB-BSIs) remains a debated issue. Herein, the efficacy and safety of a loading dose (LD) followed by extended/continuous infusion (EI/CI) versus intermittent bolus (IB) of these drugs for the treatment of GNB-BSIs was evaluated.

Methods

This is a retrospective observational study enrolling patients with GNB-BSIs treated with β-lactams from 1 October 2020 to 31 March 2022. The 30 day infection-related mortality rate was assessed with Cox regression, while mortality risk reduction was evaluated by an inverse probability of treatment weighting regression adjustment (IPTW-RA) model.

Results

Overall, 224 patients were enrolled: 140 and 84 in the IB and EI/CI groups, respectively. β-Lactam regimens were chosen according to pathogen antibiogram, clinical judgement and current guidelines. Interestingly, the LD + EI/CI regimen was associated with a significant lower mortality rate (17% versus 32%, P = 0.011). Similarly, β-lactam LD + EI/CI was significantly associated with a reduced risk of mortality at multivariable Cox regression [adjusted HR (aHR) = 0.46; 95%CI = 0.22–0.98; P = 0.046]. Finally, the IPTW-RA (adjusted for multiple covariates) was performed, showing a significant risk reduction in the overall population [−14% (95% CI = −23% to −5%)]; at the subgroup restricted analysis, a significant risk reduction (>15%) was observed in the case of GNB-BSI in severely immunocompromised patients (P = 0.003), for SOFA score > 6 (P = 0.014) and in septic shock (P = 0.011).

Conclusions

The use of LD + EI/CI of β-lactams in patients with a GNB-BSI may be associated with reduced mortality; also in patients with severe presentation of infection or with additional risk factors, such as immunodepression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gram-Negative Bacterial InfectionsSepsisBacteremiaHumansbeta-LactamsAnti-Bacterial AgentsRetrospective StudiesPropensity ScoreGram-Negative Bacteria

Substanzen

beta-LactamsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Clinic of Infectious Diseases, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, Policlinic of Bari, Piazza Giulio Cesare n. 11, 70124 Bari, Italy.
  • Section of Microbiology and Virology, University of Bari, Policlinic of Bari, Piazza Giulio Cesare n. 11, 70124 Bari, Italy.
  • Hospital Pharmacy Department, University of Bari, Policlinic of Bari, Piazza Giulio Cesare n. 11, 70124 Bari, Italy.
  • Anesthesia and Intensive Care Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, Policlinic of Bari, Piazza Giulio Cesare n. 11, 70124 Bari, Italy.

Zitieren

APA

Bavaro, D. F., Belati, A., Diella, L., Frallonardo, L., Guido, G., Papagni, R., Pellegrino, C., Brindicci, G., De Gennaro, N., Di Gennaro, F., Denicolò, S., Ronga, L., Mosca, A., Pomarico, F., Dell'Aera, M., Stufano, M., Dalfino, L., Grasso, S., & Saracino, A. (2023). Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a propensity score-adjusted retrospective cohort study. Journal of Antimicrobial Chemotherapy, 78(9), 2175-2184. https://doi.org/10.1093/jac/dkad215

Vancouver

Bavaro DF, Belati A, Diella L, Frallonardo L, Guido G, Papagni R, et al. Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a propensity score-adjusted retrospective cohort study. Journal of Antimicrobial Chemotherapy. 2023;78(9):2175-2184. doi:10.1093/jac/dkad215

BibTeX
@article{Bavaro2023,
  author = {Bavaro, Davide Fiore and Belati, Alessandra and Diella, Lucia and Frallonardo, Luisa and Guido, Giacomo and Papagni, Roberta and Pellegrino, Carmen and Brindicci, Gaetano and De Gennaro, Nicolò and Di Gennaro, Francesco and Denicolò, Sofia and Ronga, Luigi and Mosca, Adriana and Pomarico, Francesco and Dell'Aera, Maria and Stufano, Monica and Dalfino, Lidia and Grasso, Salvatore and Saracino, Annalisa},
  title = {Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a propensity score-adjusted retrospective cohort study},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2023},
  volume = {78},
  number = {9},
  pages = {2175--2184},
  doi = {10.1093/jac/dkad215}
}
Kostenlos starten →